Literature DB >> 11386002

[Modification of proteolytic complement cascade after treatment with exogenous heparin].

L V Galebskaia1, I L Solovtsova, E V Riumina.   

Abstract

The influence of heparin therapeutic concentrations (0.25-10 U/ml) on the kinetic indices of human serum complement activity has been studied. An acceleration of complement-dependent lysis of rabbit erythrocytes via alternative complement pathway was found at low (0.25-0.5 U/ml) heparin concentrations and complement inhibition at higher (5-10 U/ml) concentration. The alternative pathway inhibition was revealed mainly by lag-period elongation of the hemolysis. Heparin in the concentrations more then 1 U/ml caused dose-dependent lowering of sheep erythrocytes hemolysis rate accompanied with reciprocal elevation of complement hemolytical capacity, which shows more "economical" consumption of complement components at heparin presence. The identical effect was observed in sera, deficient in factor D of alternative pathway of complement activation. This can be an evidence of the prevailing heparin inhibition of the classical pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386002

Source DB:  PubMed          Journal:  Vopr Med Khim        ISSN: 0042-8809


  2 in total

1.  New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.

Authors:  F Poppelaars; J Damman; E L de Vrij; J G M Burgerhof; J Saye; M R Daha; H G Leuvenink; M E Uknis; M A J Seelen
Journal:  Clin Exp Immunol       Date:  2016-04-13       Impact factor: 4.330

Review 2.  A Family Affair: Addressing the Challenges of Factor H and the Related Proteins.

Authors:  Felix Poppelaars; Elena Goicoechea de Jorge; Ilse Jongerius; Antje J Baeumner; Mark-Steven Steiner; Mihály Józsi; Erik J M Toonen; Diana Pauly
Journal:  Front Immunol       Date:  2021-03-30       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.